What is the Share Price of Anuh Pharma Ltd?
- Answer Field
-
The share price of Anuh Pharma Ltd for NSE is ₹ 167.5 and for BSE is ₹ 167.55.
BAJAJ BROKING
Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply
As of the latest trading session, ANUH PHARMA LIMITED share price is currently at ₹ 167.5, which is down by ₹ -6.03 from its previous closing. Today, the stock has fluctuated between ₹ 167.10 and ₹ 173.15. Over the past year, ANUH PHARMA LIMITED has achieved a return of 0.00 %. In the last month alone, the return has been 8.92 %. Read More...
Particulars | DEC 2024 (Values in Cr) |
---|---|
Revenue | 159.51 |
Operating Expense | 147.19 |
Net Profit | 10.34 |
Net Profit Margin (%) | 6.48 |
Earnings Per Share (EPS) | 2.06 |
EBITDA | 15.72 |
Effective Tax Rate (%) | 22.00 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 19.60 | 1.99 | 279.41 | 34.11 / 77.70 |
BLISS GVS PHARMA LTD | 119.00 | 15.60 | 1.24 | 1253.91 | 92.25 / 184.95 |
CIPLA LTD | 1549.65 | 25.08 | 4.41 | 125155.99 | 1310.05 / 1702.00 |
FERMENTA BIOTECH LIMITED | 260.70 | 21.60 | 2.64 | 767.27 | 145.00 / 449.00 |
GLAXOSMITHKLINE PHARMA LT | 2959.45 | 58.70 | 29.97 | 50134.87 | 1924.30 / 3147.45 |
Company Name | Price | P/E | P/B | Market Cap | 52 Week Low/High |
---|---|---|---|---|---|
AMBALAL SARABHAI ENTERPRISES L | 36.46 | 21.96 | 6.19 | 279.41 | 34.11 / 77.70 |
AMRUTAJAN HEALTH LTD | 692.80 | 40.61 | 6.72 | 2002.93 | 548.05 / 861.40 |
ASTRAZENECA PHARMA IND LT | 8665.50 | 129.24 | 31.88 | 21663.75 | 5000.00 / 9199.00 |
BLISS GVS PHARMA LTD | 119.00 | 15.45 | 1.22 | 1253.91 | 92.25 / 184.95 |
Anuh Pharma Ltd is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The Company is engaged in the business of manufacturing and selling of 'Bulk drugs and chemicals Their products are antibiotics, erythromycin salts, chloramphenicol and other chemicals. The company is part of the SK Group.
Anuh Pharma Ltd was incorporated on February 19, 1960. The company is well positioned to service their existing and potential markets through their manufacturing operations at Tarapur in Maharashtra. All the facilities are built and operated according to cGMP. They also received plant approvals from several MNCs.
The business headquarters of the firm is located in the commercial capital of India, Mumbai. The company is a recognized export house and exports their products to Mexico, Brazil, Iran, Bangladesh, Colombia, Germany, Africa, Singapore and several other countries.
During the year 2006-07, the company commissioned the new plant with all latest modern techniques and facilities. Thus, the production capacity of Antibiotics increased from 400,000 Kg to 600,000 Kg.
During the year 2008-09, the company completed the on-going expansion of their plant, thus they increased the installed capacity by 150 MT per annum. In September 2008, they expanded unit started commercial production.
In January 2010, the company received approval for their product Erythromycin E.P. from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Erythromycin E.P. in European counties for their own consumption.
In April 2010, the company received approval for their product Pyrazinamide from European Directorate for the Quality of Medicines & HealthCare (EDQM). This approval paves the way for the company to sell Pyrazinamide in European countries for their own consumption.
In June 2010, the company received approval for their product Clobetasol Propionate from European Directorate for the Quality Medicines & Healthcare. This approval paves the way for the company to sell Clobetasol Propionate in European counties for their own consumption.
The erection of a new plant for manufacture of drug intermediates, was completed during the year 2010-11 and it got commissioned towards end of February, 2011.
In 2012, it received WHO - PQ for Pyrazinamide & acquired R&D assets in Mahape, Navi Mumbai & got DSIR approval. In 2014, it got approval from COFEPRIS - Mexico for Erythromycin Estolate, Erythromycin Stearate, Erythromycin Ethyl Succinate. In 2015, it received approval of WHO - PQ for Sulfadoxine.
In March 2019, the Company opened new expansion with an additional capacity of 900 MTPA for 20 different products. It received CEP for Ambroxol Hydrochloride from EDQM in 2022.
The share price of Anuh Pharma Ltd for NSE is ₹ 167.5 and for BSE is ₹ 167.55.
The market cap of Anuh Pharma Ltd for NSE is ₹ 8,39.50 Cr. and for BSE is ₹ 0.0 Cr. as of now.
The 52 Week High and Low of Anuh Pharma Ltd for NSE is ₹ 245.70 and ₹ 148.50 and for BSE is ₹ 258.00 and ₹ 148.05.
You can trade in Anuh Pharma Ltd shares with Bajaj Broking by opening a Demat Account.
The 1 year returns on the stock has been 0.00%.
Anuh Pharma Ltd share price is for NSE ₹ 167.5 & for BSE ₹ 167.55 as on Apr 30 2025 03:29 PM.
The market cap of Anuh Pharma Ltd for NSE ₹ 8,39.50 & for BSE ₹ 0.0 as on Apr 30 2025 03:29 PM.
As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Anuh Pharma Ltd share is 16.70.
As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Anuh Pharma Ltd share is 60.48.
You can trade in Anuh Pharma Ltd shares with Bajaj Broking by opening a demat account.
To buy Anuh Pharma Ltd shares on the Bajaj Broking app, follow these steps:
• Login to the Bajaj Broking App
• Click on the Search Icon
• Search “Anuh Pharma Ltd”
• Click on the BUY icon
• Place a buy order specifying the desired quantity of shares.
• Click BUY again to complete the purchase
No results found